Sign in

CIK 0001721484

  • Emerging growth company

Longeveron Inc.

Sign in to watch
Ticker
LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472174146
Phone
+1 305-302-7158
Business address
1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
Former names
LONGEVERON LLC
  1. 4 Grant or award Director acquired 23,500 shares (grant or award)
  2. 4 Grant or award Director acquired 23,500 shares (grant or award)
  3. 4 Grant or award Director acquired 23,500 shares (grant or award)
  4. 4 Grant or award Director acquired 23,500 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 4 Grant or award Director acquired 16,000 shares (grant or award)
  8. 4 Grant or award Director acquired 16,000 shares (grant or award)
  9. 4 Shares withheld for taxes Chief Financial Officer gave up 357 shares (to pay taxes)
  10. 4 Shares withheld for taxes Director gave up 125 shares (to pay taxes)
  11. 4 Shares withheld for taxes General Counsel, Secretary gave up 325 shares (to pay taxes)
  12. 4 Grant or award Director acquired 16,000 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Shares withheld for taxes Chief Financial Officer gave up 410 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Medical Officer gave up 308 shares (to pay taxes)
  16. 4 Open-market buy Chief Scientific Officer bought 148,936 shares at $2.35 ($350,000)
  17. 4 Open-market buy Chief Executive Officer bought 10,638 shares at $2.35 ($24,999)
  18. 4 Open-market buy Director bought 138,298 shares at $2.35 ($325,000)
  19. 4 Shares withheld for taxes Chief Executive Officer gave up 32,866 shares (to pay taxes)
  20. 4 Derivatives Options or other derivatives

Page 6 of 13 · 246 filings